Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced melanoma

查看全文 作　　者：WEBER JS; DUMMER R; DE PRIL V; 出　　处：《Cancer》索引2013年第119卷第9期,共0页